Through the LIFE study, we examined how frailty and functional status evolve over time in older adults with advanced hepatocellular carcinoma—and how these patient-centered measures complement traditional and new liver prognostic scores.
📍 Poster Boards B16 & B22
Come by! -#GI26
So proud of lead author @coltonjones presenting his research at #GI26
This week! @mayscancer@UTHealthSA
Ozempic, Wegovy Might Lower Colon Cancer Risk https://t.co/I1Coi1i0tw
We show for the first time that a high-fiber diet is a low-risk intervention that may delay progression to myeloma. This project is truly team science and an amazing collaborative effort that spans multiple institutions, 3 countries and 7 years. #ASH25#mmsm
From Canada to Netherlands to India, this week was all about how the world delivers geriatric oncology + palliative care @SIOGorg in Belgium! I also shared our LIFE study on functional status in advanced HCC���spotlighting key differences by age. Grateful for the journey.